Medical Management of Diabetes and Heart Disease - part 6 pdf

Medical Management of Diabetes and Heart Disease - part 6 pdf

Medical Management of Diabetes and Heart Disease - part 6 pdf

... 1988; 66 :580–583. 16. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnor- malities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 19 96; ... diabetes in the world ( 16) . Evidence for an enhanced rate of development of diabetes is also evident from long-term follow-up of women with PCOS (17). PCO and Insulin Resist...

Ngày tải lên: 14/08/2014, 07:20

31 363 0
Medical Management of Diabetes and Heart Disease - part 1 pps

Medical Management of Diabetes and Heart Disease - part 1 pps

... NY 100 16 tel: 21 2 -6 9 6- 9 000; fax: 21 2 -6 8 5-4 540 Eastern Hemisphere Distribution Marcel Dekker AG Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland tel: 4 1 -6 1-2 6 1-8 482; fax: 4 1 -6 1-2 6 1-8 8 96 World ... 45: 166 1– 166 9. 23. Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibi- tor type-1 by insulin and insulin-like...

Ngày tải lên: 14/08/2014, 07:20

31 274 0
Medical Management of Diabetes and Heart Disease - part 2 pps

Medical Management of Diabetes and Heart Disease - part 2 pps

... Report of the expert committee on the diagnosis and classification of diabetes melli- tus. Diabetes Care 2001; 24(suppl 1):S5–S20. 2. Wingard DL, Barrett-Cannor E. Heart disease and diabetes. In: Diabetes ... secretion and insulin action in non-insulin-dependent diabetes mel- litus are inherited: Metabolic studies on offspring of diabetic probands. J Clin Invest 1998;...

Ngày tải lên: 14/08/2014, 07:20

31 480 0
Medical Management of Diabetes and Heart Disease - part 3 ppt

Medical Management of Diabetes and Heart Disease - part 3 ppt

... Hemmings BA, Ballmer-Hofer K, Thelen M. Constitu- tive activation of protein kinase B and phosphorylation of p47phox by a membrane- targeted phosphoinositide 3-kinase. Curr Biol 19 96; 6: 1271–1278. 55. ... of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340: 67 7 68 4. 68 . UK Prospective Diabetes Study Group. Tight b...

Ngày tải lên: 14/08/2014, 07:20

31 393 0
Medical Management of Diabetes and Heart Disease - part 4 docx

Medical Management of Diabetes and Heart Disease - part 4 docx

... evolution and persistence of thrombosis and the rapidity and extent of lysis of thrombi associated with vascular damage and its repair, overexpression of PAI-1 is likely to exacerbate both devel- opment ... concentra- tion of PAI-1 in blood in normal subjects. Both phenomena, hormonal (hyperin- sulinemia) and metabolic (hyperglycemia and hypertriglyceridemia) derange- me...

Ngày tải lên: 14/08/2014, 07:20

31 342 0
Medical Management of Diabetes and Heart Disease - part 5 pot

Medical Management of Diabetes and Heart Disease - part 5 pot

... (IRS-1 and IRS-2), and activation of the phosphoinositol 3′ kinase (PI-3′-K) pathway. On the other hand, cell growth and differentiation are regu- lated primarily by the SHC, GRB-2, and the MAP-kinase ... concentration of 1 26 mg/dL and the 2-h OGTT value of 200 mg/dL and both of these levels correlate well with the appearance of microvascular complications of diabet...

Ngày tải lên: 14/08/2014, 07:20

31 349 0
Medical Management of Diabetes and Heart Disease - part 7 pps

Medical Management of Diabetes and Heart Disease - part 7 pps

... effect of nisoldipine as compared with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 64 5 65 2. 26. Fein F, Scheur J. Heart disease in diabetes mellitus: theory and practice. ... lev- els of high-density-lipoprotein (HDL) cholesterol, and increased low-density-li- poprotein (LDL) cholesterol, hypertension, and central obesity with an increased...

Ngày tải lên: 14/08/2014, 07:20

31 334 0
Medical Management of Diabetes and Heart Disease - part 9 docx

Medical Management of Diabetes and Heart Disease - part 9 docx

... PTCA- and CABG-treated patients even in subgroups of diabetes and three-vessel disease (31). In addition to the randomized trials com- paring PCI and CABG, three large, single-center registries and ... time of restenosis, that is 3 to 4 months post-intervention. For long-term follow-up of 268 Peragallo-Dittko Table 3 Recommendations Regarding Diabetes and Smoking Assessm...

Ngày tải lên: 14/08/2014, 07:20

31 304 0
Medical Management of Diabetes and Heart Disease - part 10 potx

Medical Management of Diabetes and Heart Disease - part 10 potx

... Department of Medicine and Professor of Biochemistry at the University of Vermont College of Medicine and Physician-in-Chief, Fletcher Allen Health Care, Burlington, Ver- mont. The editor of Medical Management ... diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113:909–915. Index 283 Cardiovascular complications, preva- lence, 66 67 Cardiovascular...

Ngày tải lên: 14/08/2014, 07:20

26 310 0
Từ khóa:
w